Preliminary data from PLX cell against COVID-19 infections reported 87.5% survival rate in eight patients in the 28 day follow up. Improvement in respiratory parameters was observed in 4 out of 6 patients and 75% patients survived without assistance of ventilators. In addition, 62.5% patients were discharged alive from the hospital in comparison to 3.3% patients requiring mechanical ventilation. One patient has shown no change in respiratory parameters, is still breathing with the assistance of a ventilator and remains relatively stable. Deterioration in respiratory parameters was observed in one patient. Two patients out of four with multi-organ failure prior to treatment, showed clinical recovery in addition to the respiratory improvement ^{[2] [1]}